Health
Study: Thymoquinone selectively kills prostate cancer cells at advanced stages – News-Medical.Net
The compound thymoquinone (TQ) selectively kills prostate cancer cells at advanced stages, according to a new study published in Oncogene.
Reviewed by Emily Henderson, B.Sc.Oct 8 2020
The compound thymoquinone (TQ) selectively kills prostate cancer cells at advanced stages, according to a new study published in Oncogene. Led by researchers at Kanazawa University, the study reports that prostate cancer cells with a deletion of the SUCLA2 gene can be therapeutically targeted.
SUCLA2-deficient prostate cancers represent a significant fraction of those resistant to hormone therapy or metastatic, and a new therapeutic option for this …
-
Noosa News13 hours agoFears for the future of retro Chinese dining after blaze guts Sundoo in Townsville
-
Business19 hours agoTop brokers name 3 ASX shares to buy next week 25 May 2025
-
Noosa News19 hours agoOn your marks, get set, buy!
-
Business16 hours agoThese ASX 200 shares could rise 20% to 100%